These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
241 related items for PubMed ID: 17898655
1. An improved application for the enzyme multipled immunoassay technique for caffeine, amikacin, and methotrexate assays on the Dade-Behring Dimension RxL Max clinical chemistry system. Mendu DR, Chou PP, Soldin SJ. Ther Drug Monit; 2007 Oct; 29(5):632-7. PubMed ID: 17898655 [Abstract] [Full Text] [Related]
2. Improved sensitivity for methotrexate analysis using enzyme multiplied immunoassay technique on the Siemens Viva-E instrument. Borgman MP, Hiemer MF, Molinelli AR, Ritchie JC, Jortani SA. Ther Drug Monit; 2012 Apr; 34(2):193-7. PubMed ID: 22377747 [Abstract] [Full Text] [Related]
3. [Evaluation of Emit netilmicin and amikacin assays on Dimension RXL HM (Dade Behring) open channels]. Vételé F, Manchon M, Mialon A, Berny C, Baltassat P. Ann Biol Clin (Paris); 2002 Apr; 60(6):723-30. PubMed ID: 12446241 [Abstract] [Full Text] [Related]
4. Interference of 7-hydroxymethotrexate with the determination of methotrexate in plasma samples from children with acute lymphoblastic leukemia employing routine clinical assays. Fotoohi K, Skärby T, Söderhäll S, Peterson C, Albertioni F. J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Mar 25; 817(2):139-44. PubMed ID: 15686977 [Abstract] [Full Text] [Related]
5. Methotrexate measurements in plasma: comparison of enzyme multiplied immunoassay technique, TDx fluorescence polarization immunoassay, and high pressure liquid chromatography. Slørdal L, Prytz PS, Pettersen I, Aarbakke J. Ther Drug Monit; 1986 Mar 25; 8(3):368-72. PubMed ID: 3529519 [Abstract] [Full Text] [Related]
6. The influence of 7-OH methotrexate metabolite on clinical relevance of methotrexate determination. Klapkova E, Kukacka J, Kotaska K, Suchanska I, Urinovska R, Prusa R. Clin Lab; 2011 Mar 25; 57(7-8):599-606. PubMed ID: 21888024 [Abstract] [Full Text] [Related]
7. Calcineurin Inhibitor Determination in Whole Blood With the RXL Dimension Analyzer: A Useful Tool for Immunosuppressive Drug Monitoring. Ventura E, Bonardet A, Pageaux GP, Mourad G, Cristol JP. Transplant Proc; 2009 Mar 25; 41(2):707-9. PubMed ID: 19328963 [Abstract] [Full Text] [Related]
8. [Evaluation of the heterogeneous immunoassay (ACMIA) for the measurement of blood cyclosporin on the Behring dimension RXL clinical chemistry analyzer]. Morand K, Huet E, Blanchet B, Astier A, Hulin A. Ann Biol Clin (Paris); 2003 Mar 25; 61(6):713-8. PubMed ID: 14711615 [Abstract] [Full Text] [Related]
9. Analysis of caffeine: comparison of the manual enzyme multiplied immunoassay (EMIT), automated EMIT, and high-performance liquid chromatography procedures. Miceli JN, Aravind MK, Ferrell WJ. Ther Drug Monit; 1984 Mar 25; 6(3):344-7. PubMed ID: 6390796 [Abstract] [Full Text] [Related]
10. Monitoring methotrexate in clinical samples from cancer patients during chemotherapy with a LSPR-based competitive sensor. Zhao SS, Bichelberger MA, Colin DY, Robitaille R, Pelletier JN, Masson JF. Analyst; 2012 Oct 21; 137(20):4742-50. PubMed ID: 22943049 [Abstract] [Full Text] [Related]
11. [Serum monitoring of methotrexate (MTX) and 7-hydroxymethotrexate concentrations in patients treated with MTX using high-pressure liquid chromatography (HPLC) and comparison of serum MTX levels between HPLC method and fluorescence polarization immunoassay (FPIA)]. Sakamoto S, Matsuhisa T, Miyoshi K, Naruse R, Urayama H, Shimokawa T, Okabe K, Toki H, Motoi M, Moriwaki S. Gan To Kagaku Ryoho; 1991 Jun 21; 18(7):1119-25. PubMed ID: 2053771 [Abstract] [Full Text] [Related]
12. [Blood concentration monitoring during high-dose methotrexate treatment]. Jiao L, Zhou DB, Wang SJ, Zhang W, Duan MH, Li J, Han B, Xu Y, Zhao YQ, Shen T, Wang Q, Ye M. Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Oct 21; 31(5):564-6. PubMed ID: 19968071 [Abstract] [Full Text] [Related]
13. The V-twin system (Dade Behring Laboratories): a useful tool for immunosuppressive drug monitoring. Elaerts S, Olejnik Y, Bonardet A, Garrigue V, Mourad G, Cristol JP, Dupuy AM. Transplant Proc; 2005 Oct 21; 37(1):167-71. PubMed ID: 15808583 [Abstract] [Full Text] [Related]
14. Effect of the hematocrit and its correction on the relationship between blood tacrolimus concentrations obtained using the microparticle enzyme immunoassay (MEIA) and enzyme multiplied immunoassay technique (EMIT). Bouzas L, Ortega FJ, Casado P, Arranz MI, Carcas A, Tutor JC. Clin Lab; 2007 Oct 21; 53(9-12):591-6. PubMed ID: 18257466 [Abstract] [Full Text] [Related]
15. Performance characteristics of a no-pretreatment, random access sirolimus assay for the Dimension RxL clinical chemistry system. Cervinski MA, Duh SH, Hock KG, Gray J, Wei TQ, Kilgore DC, Christenson RH, Scott MG. Clin Biochem; 2009 Jul 21; 42(10-11):1123-7. PubMed ID: 19303402 [Abstract] [Full Text] [Related]
16. Comparison of enzyme immunoassay, radioimmunoassay, and microbiologic assay for amikacin in plasma. Fukuchi H, Yoshida M, Tsukiai S, Kitaura T, Konishi T. Am J Hosp Pharm; 1984 Apr 21; 41(4):690-3. PubMed ID: 6372450 [Abstract] [Full Text] [Related]
18. Unexpected overestimation of methotrexate plasma concentrations: analysis of a single center pediatric population. Guerriero E, Simon N, Nelken B, Baldeyrou B, Djobo B, Vasseur M, Allorge D, Décaudin B, Odou P. Ther Drug Monit; 2014 Aug 21; 36(4):499-504. PubMed ID: 25014075 [Abstract] [Full Text] [Related]